What Is Arrhythmogenic Right Ventricular Cardiomyopathy & What Causes It?
Despite the commonly used name, arrhythmogenic cardiomyopathy is not restricted to the right ventricle. This is just the variety that was first identified. Research has found that there are several types of ACM, including variants that predominantly affect the right ventricle (ARVC; also called arrhythmogenic right ventricular dysplasia [ARVD]), the left ventricle (left-dominant arrhythmogenic cardiomyopathy [LDAC]) or both (biventricular arrhythmogenic cardiomyopathy).
Regardless of the type of ACM you have, the same issue occurs, wherein your heart muscle is replaced with scar tissue (fibrosis) and (often) fat due to an inherited genetic condition. The fibrosis and fat affect the transmission of electrical signals through your heart, affecting how it beats. As a result, you may experience arrhythmias or irregular heartbeats. These arrhythmias in some patients can cause the individual to lose consciousness or even die suddenly. Similarly, because the heart cannot beat as effectively or normally, it is not as competent at pumping blood around your body. In extreme circumstances, this can then lead to heart failure.
It is important to know, though, that ACM can vary between individuals. While some may experience progressive heart issues, others may find the disease remains stable. Others again may have very minor changes that can only be detected by a skilled cardiologist who is intimately familiarly with the disease.
As a genetic heart condition, ACM is usually inherited and cannot be acquired. In order to develop ACM, you need to inherit it from a parent or have the relevant gene spontaneously mutate at conception. While ACM is autosomal dominant (this means that only one half of the pair of genes needs to be affected for you to inherit the condition), who is affected and how severely varies greatly.
While research is ongoing into which genes and mutations are responsible for the condition, many have been identified and are well understood. For instance, research has identified that changes to the junction plakoglobin (JUP) or desmocollin (DSC2) genes often mean the patient has ARVC rather than LDAC. In contrast, mutations in the desmoplakin (DSP) gene are more likely to cause LDAC or biventricular ACM. Knowing which genes and mutations can cause ACM allows doctors to use genetic testing to confirm an ACM diagnosis.